US$1.62 Billion Market in 2026: Recombinant DNA Technology Enables Yeast and CHO Cell-Derived Hepatitis B Vaccines, Providing Long-Term Protection Against HBV Infection and Liver Cancer

Hepatitis B Vaccines Market Summary

Hepatitis B Vaccines are preventive biological products developed using hepatitis B surface antigen (HBsAg), typically produced through recombinant DNA technologies such as yeast or mammalian cell expression systems. These vaccines stimulate the immune system to generate specific antibodies against the hepatitis B virus (HBV), providing long-term protection against infection. Administered in multi-dose schedules, they are suitable for newborns, children, and adults, playing a critical role in preventing mother-to-child transmission and protecting high-risk populations. As a key component of national immunization programs, hepatitis B vaccines have significantly reduced infection rates and associated complications such as cirrhosis and liver cancer. With ongoing advancements in vaccine technology and immunization strategies, these vaccines are evolving toward higher immunogenicity, longer-lasting protection, and combination vaccine formats.

According to the new market research report “Global Hepatitis B Vaccines Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032”, published by Global Info Research  the global Hepatitis B Vaccines market size was valued at US$ 1617 million in 2026 and is forecast to a readjusted size of US$ 2333 million by 2032 with a CAGR of 6.3% during review period.

Figure1. Global Hepatitis B Vaccines Market Size (US$ Million), 2021-2032

Figure2. Global Hepatitis B Vaccines Top 9 Players Ranking and Market Share (Ranking is based on the revenue of 2025, continually updated)

According to Global Info Research Top Players Research Center, the global key manufacturers of Blood Pressure Monitors include GSK, Dynavax, etc. In 2025, the global top three players had a share approximately 62.0% in terms of revenue.

Figure3. Hepatitis B Vaccines, Global Market Size, Split by Product Segment

In terms of product type, currently Yeast Derived is the largest segment, hold a share of 85.7%.

Figure4. Hepatitis B Vaccines, Global Market Size, Split by Application Segment

In terms of product application, currently Children is the largest segment, hold a share of 66.8%.

Figure5. Hepatitis B Vaccines, Global Market Size, Split by Region (Sales)

Figure6. Hepatitis B Vaccines, Global Market Size, Split by Region

Driven by China’s strengthening public health system and ongoing viral hepatitis control strategies, the hepatitis B vaccine market maintains a solid foundation for long-term growth. Government immunization programs provide free vaccination for children, significantly improving coverage and reducing infection rates, forming a stable demand base. Collaborative initiatives between China and Gavi, the Vaccine Alliance have demonstrated that financial support and policy-driven vaccine expansion can effectively enhance accessibility and coverage. Meanwhile, growing awareness of adult vaccination, occupational exposure protection, and high-risk population management is expanding demand beyond pediatric immunization toward full-population coverage. Global immunization initiatives and technological advancements further reinforce industry growth momentum.

Operating under strict regulatory frameworks, the industry faces high entry barriers and compliance requirements. Vaccine products must undergo rigorous clinical validation and batch release processes, increasing R&D and production costs. Safety concerns and public perception risks remain critical, as historical events have shown strong sensitivity to vaccine-related incidents. Additionally, centralized procurement and pricing control mechanisms in China exert pressure on profit margins, requiring companies to balance quality assurance, innovation, and cost efficiency.

Demand is evolving from mandatory neonatal immunization toward full lifecycle vaccination management. While newborn vaccination remains the core, adult booster vaccination, occupational protection, and re-vaccination for immunization gaps are expanding. Studies indicate that hepatitis B incidence in China has significantly declined due to vaccination efforts, yet long-term management demand persists. Furthermore, increasing health awareness and preventive screening are integrating vaccines into broader health management systems, driving demand toward higher frequency and precision.

Key upstream components include recombinant expression systems (such as yeast strains), culture media, adjuvants (e.g., aluminum salts), purification reagents, and sterile packaging materials. Antigen expression efficiency and purification processes are critical determinants of vaccine quality and efficacy. China has developed a comprehensive vaccine production system with large-scale manufacturing capacity, forming a strong industrial foundation. With advancements in biotechnology and cell culture techniques, upstream capabilities are evolving toward higher purity, stability, and scalability, although challenges remain in advanced process control and next-generation adjuvant technologies, driving continued value chain upgrading.

Hepatitis B Vaccines Report Chapter Summary:
Chapter 1: Hepatitis B Vaccines Industry Definition and Market Overview
This chapter clearly defines the product definition, characteristics, and industry statistical scope of Hepatitis B Vaccines, systematically introduces its mainstream product classifications and key application areas, and presents the overall size and future outlook of the global market.
Chapter 2: In-depth Analysis of Core Hepatitis B Vaccines Companies (2021-2025)
This chapter focuses on the main players in the Hepatitis B Vaccines market. For each representative company, it not only introduces its basic overview, main business, and product portfolio, but also highlights its core operating data in the Hepatitis B Vaccines field, including sales volume, sales revenue, pricing strategies, and the latest development trends of the company from 2021 to 2025.
Chapter 3: Global Competitive Landscape Analysis (2021-2025)
This chapter examines the global Hepatitis B Vaccines competitive landscape from a macro perspective. By comparing the Hepatitis B Vaccines sales volume, pricing, revenue, and market share of major companies from 2021 to 2025, it quantitatively analyzes market concentration and interprets the competitive strategies and market position evolution of core manufacturers.
Chapter 4: Hepatitis B Vaccines Major Regional Market Size and Prospects (2021-2032)
This chapter conducts a regional-level analysis of the global Hepatitis B Vaccines core markets. It will present historical data on the Hepatitis B Vaccines market size (sales volume and revenue from 2021-2025) in major regions such as North America, Europe, and Asia Pacific, and provide market outlook forecasts for 2026-2032.
Chapter 5: Hepatitis B Vaccines Product Type Segmentation Market Forecast (2021-2032)
This chapter delves into the Hepatitis B Vaccines product structure. It will segment the Hepatitis B Vaccines market by different types (such as Yeast Derived、CHO Derived, etc.), and analyze in detail the historical market size of each segmented product category from 2021 to 2025 and the future growth trends from 2026 to 2032.
Chapter 6: Hepatitis B Vaccines Application Field Segmentation Market Forecast (2021-2032)
This chapter delves into the downstream application demand for Hepatitis B Vaccines. The market will be segmented by different application areas (such as Children、Adult, etc.), presenting the historical market size for each area from 2021-2025 and future demand forecasts from 2026-2032.
Chapters 7-11: In-depth Analysis of Global Regional Markets (2021-2032)
This section is the core module of the Hepatitis B Vaccines report, providing an in-depth country/regional analysis across five major regions: North America, Europe, Asia Pacific, South America, and the Middle East & Africa. The chapter structure for each region is consistent:
Segmentation by Country/Region: Analysis of the market size and forecasts for major countries within the region from 2021-2032.
Segmentation by Product Type: Presentation of the market structure and development forecasts for different product types within the region from 2021-2032.
Segmentation by Application Area: Analysis of market demand and prospects for different application areas within the region from 2021-2032.
Chapter 12: Global Hepatitis B Vaccines Market Dynamics, Challenges, and Trends
This chapter aims to analyze the key internal and external factors affecting the development of the Hepatitis B Vaccines market. It systematically reviews the core drivers of Hepatitis B Vaccines market growth, the main obstacles and challenges faced, and assesses future product, technology, and market development trends.
Chapter 13: Hepatitis B Vaccines Industry Chain Structure Analysis
This chapter analyzes the entire industry chain ecosystem of the Hepatitis B Vaccines industry. From upstream raw material supply to midstream production and manufacturing, and then to downstream end-use applications, it analyzes the current status, cost structure, and collaborative relationships of each link.
Chapter 14: Sales Channel Model Research
This chapter focuses on the distribution channels of Hepatitis B Vaccines products. It analyzes the market share, advantages and disadvantages, and typical cases of mainstream sales channels, and explores the innovation and development trends of channel models.
Chapter 15: Research Conclusions and Strategic Recommendations
As a summary of the report, this chapter will distill the core findings and conclusions of the entire report and, based on a comprehensive understanding of the Hepatitis B Vaccines market, provide actionable strategic development recommendations for industry participants and potential entrants.

For more information, please refer to "Global Hepatitis B Vaccines Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032". This report analyzes the supply and demand situation, development status, and changes in the industry, focusing on the development status of the industry, how to face the development challenges of the industry, industry development suggestions, industry competitiveness, and industry investment analysis and trend forecasts. The report also summarizes the overall development dynamics of the industry, including the impact of the latest US tariffs on the global supply chain, the supply relationship analysis of the industrial chain, and provides reference suggestions and specific solutions for the industry in terms of products.